Clinical Trial Update: CoQ10 and Prednisone in Non-Ambulatory DMD [Phase 3]

View source ↗

Summary

Phase 3 trial of CoQ10 in combination with Prednisone in non-ambulatory Duchenne muscular dystrophy was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• CoQ10 (coenzyme Q10)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: TERMINATED | Results posted: 2013-10-11